2021
DOI: 10.1089/fpd.2020.2898
|View full text |Cite
|
Sign up to set email alerts
|

Detection of Extended-Spectrum Beta-Lactamase-Producing and Carbapenem-Resistant Bacteria from Mink Feces and Feed in the United States

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 32 publications
0
6
0
Order By: Relevance
“…Therefore, the use of antibiotics especially PLOS GLOBAL PUBLIC HEALTH from male admitted patients should always be proven by susceptibility testing. The resistant trend observed in this study clearly indicate possible prevalence of extended spectrum beta lactamases (ESBLs) [23], and E. agglomerans, K. pneumonia and S. aureus are clinically important pathogens that can develop multidrug resistance and cause difficult to treat infections in all age groups [24,25]. Imipenem is a carbapenem that shows broad-spectrum activity against gram-positive, gram-negative, and anaerobic bacteria, and is active against cephalosporinresistant Enterobacteriaceae producing ESBLs, whereas piperacillin/tazobactam is the combination of a fourth generation, extended-spectrum penicillin and a beta-lactamase inhibitor that is also effective against β-lactamase producing penicillin-resistant bacterial species [26,27].…”
Section: General Characterization Of Bacterial Isolates From Routine ...mentioning
confidence: 62%
“…Therefore, the use of antibiotics especially PLOS GLOBAL PUBLIC HEALTH from male admitted patients should always be proven by susceptibility testing. The resistant trend observed in this study clearly indicate possible prevalence of extended spectrum beta lactamases (ESBLs) [23], and E. agglomerans, K. pneumonia and S. aureus are clinically important pathogens that can develop multidrug resistance and cause difficult to treat infections in all age groups [24,25]. Imipenem is a carbapenem that shows broad-spectrum activity against gram-positive, gram-negative, and anaerobic bacteria, and is active against cephalosporinresistant Enterobacteriaceae producing ESBLs, whereas piperacillin/tazobactam is the combination of a fourth generation, extended-spectrum penicillin and a beta-lactamase inhibitor that is also effective against β-lactamase producing penicillin-resistant bacterial species [26,27].…”
Section: General Characterization Of Bacterial Isolates From Routine ...mentioning
confidence: 62%
“…However, because the incidence is low and the use of antibiotics is minimal, drug resistance genes are much less likely to spread. A US study reported that 39 out of 42 stool samples contained E. coli carrying CTX-M (93%) (53). In another German prevalence survey on ESBL-producing E. coli, 96.5% of calves in the 10 large rural villages involved were ESBL-positive, 92.9% of which were E. coli (54).…”
Section: Discussionmentioning
confidence: 99%
“…A US study reported that 39 out of 42 stool samples contained E. coli carrying CTX-M (93%) ( 53 ). In another German prevalence survey on ESBL-producing E. coli , 96.5% of calves in the 10 large rural villages involved were ESBL-positive, 92.9% of which were E. coli ( 54 ).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the use of antibiotics especially from male admitted patients should always be proven by susceptibility testing. The resistant trend observed in this study clearly indicate possible prevalence of extended spectrum beta lactamases (ESBLs) (21), and Enterobacter agglomerans, Klebsiella pneumonia and Staphylococcus aureus are clinically important pathogens that can develop multidrug resistance and cause difficult to treat infections in all age groups (22, 23). Imipenem is a carbapenem that shows broad-spectrum activity against gram-positive, gram-negative, and anaerobic bacteria, and is active against cephalosporin-resistant Enterobacteriaceae producing ESBLs, whereas piperacillin/tazobactam is the combination of a fourth generation, extended-spectrum penicillin and a beta-lactamase inhibitor that is also effective against β-lactamase producing penicillin-resistant bacterial species (24, 25).…”
Section: Discussionmentioning
confidence: 79%